We are live on ! Find out more
MLA

MB, Levis & Associates Portfolio holdings

AUM $271M
1-Year Est. Return 15.56%
This Fund
S&P 500
This Quarter Est. Return
+4.83%
1 Year Est. Return
+15.56%
3 Year Est. Return
+39.99%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$228M
AUM Growth
+$12.2M
Cap. Flow
+$3.41M
Cap. Flow %
1.5%
Top 10 Hldgs %
63.73%
Holding
286
New
3
Increased
89
Reduced
21
Closed
20

Top Buys

Rank Stock Value
1
VV icon
Vanguard Morningstar Large-Cap ETF
VV
+$584K
2
QGRO icon
American Century US Quality Growth ETF
QGRO
+$338K
3
IBDX icon
iShares iBonds Dec 2032 Term Corporate ETF
IBDX
+$295K
4
VTEB icon
Vanguard Tax-Exempt Bond Index Fund
VTEB
+$294K
5
BSMW icon
Invesco BulletShares 2032 Municipal Bond ETF
BSMW
+$216K

Top Sells

Rank Stock Value
1
BME icon
BlackRock Health Sciences Trust
BME
+$58K
2
BND icon
Vanguard Total Bond Market
BND
+$52.1K
3
JPM icon
JPMorgan Chase
JPM
+$42.1K
4
KMI icon
Kinder Morgan
KMI
+$37.2K
5
FDX icon
FedEx
FDX
+$23.6K

Sector Composition

Rank Sector Weight
1 Technology 7.83%
2 Industrials 4.33%
3 Healthcare 3.93%
4 Financials 3.43%
5 Consumer Staples 2.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FCX icon
251
Freeport-McMoran
FCX
$90B
$1.09K ﹤0.01%
25
– –
FVRR icon
252
Fiverr
FVRR
$321M
$939 ﹤0.01%
32
– –
DOCU
253
DocuSign
DOCU
$10.5B
$779 ﹤0.01%
10
– –
PATH icon
254
UiPath
PATH
$6.61B
$640 ﹤0.01%
50
– –
CRON
255
Cronos Group
CRON
$1.06B
$630 ﹤0.01%
330
– –
BRCC icon
256
BRC Inc
BRCC
$121M
$459 ﹤0.01%
350
– –
KPTI icon
257
Karyopharm Therapeutics
KPTI
$43.5M
$431 ﹤0.01%
100
– –
VTRS icon
258
Viatris
VTRS
$20.4B
$419 ﹤0.01%
47
-278
-86% -$2.35K
OSUR icon
259
OraSure Technologies
OSUR
$279M
$375 ﹤0.01%
125
– –
EVGO icon
260
EVgo
EVGO
$223M
$365 ﹤0.01%
100
– –
BAND
261
Bandwidth Inc
BAND
$1.26B
$302 ﹤0.01%
19
– –
DNN icon
262
Denison Mines
DNN
$2.54B
$277 ﹤0.01%
152
– –
RUM icon
263
RUM Group Inc
RUM
$1.61B
$207 ﹤0.01%
23
– –
ICSH icon
264
iShares Ultra Short Duration Bond Active ETF
ICSH
$8.07B
$90 ﹤0.01%
2
– –
FIRY
265
Firy Inc
FIRY
$148M
$48 ﹤0.01%
7
– –
ORGNW
266
DELISTED
Origin Materials Inc Warrants
ORGNW
$38 ﹤0.01%
2,000
– –
BB icon
267
BlackBerry
BB
$4.98B
– –
-4
Closed -$15
BME icon
268
BlackRock Health Sciences Trust
BME
$562M
– –
-1,500
Closed -$58K
CGC
269
Canopy Growth
CGC
$387M
– –
-15
Closed -$14
DG icon
270
Dollar General
DG
$28B
– –
-12
Closed -$1.05K
EMB icon
271
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$15B
– –
-34
Closed -$3.06K
ILTB icon
272
iShares Core 10+ Year USD Bond ETF
ILTB
$592M
– –
-45
Closed -$2.27K
IUSV icon
273
iShares Core S&P US Value ETF
IUSV
$27.2B
– –
-24
Closed -$2.2K
JD icon
274
JD.com
JD
$44.6B
– –
-25
Closed -$1.03K
KT icon
275
KT
KT
$8.62B
– –
-100
Closed -$1.77K
8 9 10
11
12

Similar funds

S
Siemens Munich, Germany $272M AUM 183.71% 1-Year Est. Return
TP
TritonPoint Partners Chevy Chase, Maryland $272M AUM
FCMV
Foresite Capital Management V Larkspur, California $271M AUM 309.87% 1-Year Est. Return
MAM
Mullooly Asset Management Wall Township, New Jersey $271M AUM 16.93% 1-Year Est. Return
MLM
Mount Lucas Management Newtown, Pennsylvania $271M AUM 25.49% 1-Year Est. Return
MCM
Moerus Capital Management New York $271M AUM 58.78% 1-Year Est. Return
SC
Seldon Capital San Francisco, California $272M AUM 90.68% 1-Year Est. Return
RP
Ravenswood Partners Mclean, Virginia $271M AUM

MB, Levis & Associates's Q2 2025 Portfolio in Review

As of Q2 2025, MB, Levis & Associates held 286 positions worth $228M, up 5.7% from $215M the previous quarter. Its ten largest holdings account for 64% of the portfolio.

MB, Levis & Associates's Q2 2025 filing shows 3 new, 89 increased, 21 reduced and 20 closed positions. Its largest new stake was Fidelity High Dividend ETF: 541 shares worth $28.1K. The largest sale was BlackRock Health Sciences Trust, an estimated $58K.

By sector, the portfolio is most concentrated in Technology at 7.8% of assets, up from 7.4% a quarter earlier, followed by Industrials and Healthcare.

  • MB, Levis & Associates's largest Q2 2025 buy was Fidelity High Dividend ETF: 541 shares worth $28.1K.
  • MB, Levis & Associates added most to Vanguard Morningstar Large-Cap ETF in Q2 2025, an estimated $584K increase.
  • MB, Levis & Associates's biggest Q2 2025 reduction was Vanguard Total Bond Market, cutting an estimated $52.1K.
  • MB, Levis & Associates fully exited BlackRock Health Sciences Trust in Q2 2025, selling an estimated $58K.
  • MB, Levis & Associates's ten largest holdings make up 64% of its $228M portfolio in Q2 2025.
  • MB, Levis & Associates opened 3 new positions and closed 20 in Q2 2025.
  • MB, Levis & Associates's portfolio value rose 5.7% quarter-over-quarter to $228M.

Based on MB, Levis & Associates's 13F filing for Q2 2025, filed 29 Jul 2025.